VERALTO CORP (VLTO)
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for VLTO
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VLTO | Retired Senior Vice President—Strategic Development, Danaher Corporation; Class I Director | 58 | ["Senior Vice President - Strategic Development of Danaher from 2014 until his retirement in February 2025", "Vice President \u2013 Strategic Development from 2005 to 2014", "Various general management and functional roles with responsibilities over sales, marketing and business development", "Long-standing experience leading Danaher\u2019s strategy function", "Expertise in mergers and acquisition program"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Mr. King served as Senior Vice President - Strategic Development of Danaher from 2014 until his retirement in February 2025, after having served as Vice President Strategic Development from 2005 to 2014. From the time he joined Danaher in 1998 until his appointment as Vice President - Strategic Development, Mr. King served in various general management and functional roles with responsibilities over sales, marketing and business development. Mr. King s long-standing experience leading Danaher s strategy function gives him keen insights into Veralto s strategy, served industries and opportunities for future growth. His role in Danaher s mergers and acquisition program is a domain expertise that is particularly valuable to Veralto given the importance of its acquisition program. In addition, through his extensive leadership experience at Danaher, he has direct understanding of the principles of VES and its culture of continuous improvement. Mr. King has served as a director of W.L.Gore Inc., a family-owned medical and industrial products company, since January 2025.